Cardiothoracic & vascular anesthesia

Pulmonary Vasodilator Response of Combined Inhaled Epoprostenol and Inhaled Milrinone in Cardiac Surgical Patients

Anesth AnalgPublished Retrospective cohort study

Authors' conclusion

A positive pulmonary vasodilator response to treatment with a combination of iE&iM before initiation of CPB was observed in 77% of patients. Higher baseline SPAP was an independent predictor of pulmonary vasodilator response, while EuroSCORE II >6.5% was a predictor of nonresponse to treatment.

Study context

Population
Patients with pulmonary hypertension (PH) or right ventricular (RV) dysfunction undergoing on-pump cardiac surgery, Montreal Heart Institute, July 2013 to December 2018
Participants
128 patients
Exposure
Responders vs Nonresponders
Outcome
Rate of positive pulmonary vasodilator response to iE&iM (increase of 20% in MAP/MPAP ratio)
Methodological detailsconsecutive patients, single-centre
  • Consecutive patients
  • Single-centre

Main finding

As reported in the abstract

Positive pulmonary vasodilator response

Responders to iE&iM treatment

77.3%

Observational data: associations, not effects.

Further findings

OutcomeOR (95% CI)P value
Predictor of response: baseline SPAPPredictor of pulmonary vasodilator response1.63 (1.24–2.16)P = 0.0006
Predictor of nonresponse: EuroSCORE II >6.5%EuroSCORE II ≤6.5% vs EuroSCORE II >6.5% · EuroSCORE II >6.5% predictor of nonresponse5.19 (1.84–14.66)P = 0.002

MPAP >30 mm Hg

P = 0.0237

Systolic pulmonary artery pressure (SPAP) >55 mm Hg

Higher proportion of responders had SPAP >55 mm Hg (responders vs nonresponders; P = .0037)
17.2% vs 3.4%

Easier separation from cardiopulmonary bypass (CPB)

Easier separation from CPB associated with response to iE&iM (P = .0181)
69.7% vs 58.6%

Very difficult separation from CPB

Higher proportion of nonresponders had very difficult separation from CPB and required IV inotropes; easy separation more frequent in responders

IV inotropes after CPB

Use of IV inotropes after CPB lower in responders (P = .0052)
8.1% vs 27.6%

Original publication

Pulmonary Vasodilator Response of Combined Inhaled Epoprostenol and Inhaled Milrinone in Cardiac Surgical Patients. Anesth Analg. Published 19 September 2022. doi:10.1213/ane.0000000000006192

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.